Synthesis and anti-ovarian cancer effects of benzimidazole-2-substituted pyridine and phenyl propenone derivatives

Future Med Chem. 2022 Dec;14(24):1835-1846. doi: 10.4155/fmc-2022-0244. Epub 2022 Nov 14.

Abstract

Background: Given the benzimidazole derivatives have anti-ovarian cancer effects, the authors aimed to determine whether benzimidazole-2-substituted pyridine and phenyl propenone derivatives exert anti-ovarian cancer activity. Materials & methods: 21 derivatives were synthesized and assayed for their antiproliferative activities. Western blotting in A2780 cells was used to detect the effects of compound A-6 on apoptosis-related proteins. Invasion, migration and apoptosis were assayed in SKOV3 cells treated with A-6. The in vivo activity was also examined. Results: A-6 could inhibit proliferation, invasion and migration and induce apoptosis in SKOV3 cells. Additionally, A-6 had potent inhibitory activity in a xenograft mouse model. Conclusion: A-6 shows potent efficacy in the treatment of ovarian cancer and may be a potential antitumor agent.

Keywords: antiproliferative effect; apoptosis-related proteins; benzimidazole; ovarian cancer; pyridine and phenyl propenone; structure–activity relationships.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents* / pharmacology
  • Antineoplastic Agents* / therapeutic use
  • Apoptosis
  • Benzimidazoles / pharmacology
  • Cell Line, Tumor
  • Cell Proliferation
  • Female
  • Humans
  • Mice
  • Ovarian Neoplasms* / drug therapy
  • Ovarian Neoplasms* / pathology
  • Pyridines / pharmacology
  • Pyridines / therapeutic use

Substances

  • Antineoplastic Agents
  • Benzimidazoles
  • Pyridines